UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Impact of Caring for Individuals With Heart Failure in the United States: A Systematic Literature Review

The Journal of cardiovascular nursing, 2024-03, Vol.39 (2), p.128

2024

Volltextzugriff (PDF)

Burden of hospitalization for heart failure in the United States: a systematic literature review

Journal of managed care & specialty pharmacy, 2022-02, Vol.28 (2), p.157

2022

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States

Journal of the American Heart Association, 2024-02, Vol.13 (4), p.e029042-e029042

2024

Volltextzugriff (PDF)

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis

Journal of critical care, 2008-03, Vol.23 (1), p.91-100

2008

Volltextzugriff (PDF)

Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19

Journal of health economics and outcomes research (Online), 2024, Vol.11 (1), p.112-121

2024

Volltextzugriff (PDF)

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

Expert opinion on drug metabolism & toxicology, 2010-10, Vol.6 (10), p.1287-1300

2010

Volltextzugriff (PDF)

Length of Stay and Hospital Costs Associated with a Pharmacodynamic-Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator-Associated Pneumonia

Pharmacotherapy, 2010-05, Vol.30 (5), p.453-462

2010

Volltextzugriff (PDF)

Response to “Duplicate patient data in a meta-analysis; A threat to validity”

Journal of critical care, 2009-03, Vol.24 (1), p.158-158

Kuti, Effie L., PharmD

2009

Volltextzugriff (PDF)

Student Measurement of Blood Pressure Using a Simulator Arm Compared with a Live Subject's Arm

American journal of pharmaceutical education, 2010-06, Vol.74 (5), p.82, Article 82

2010

Volltextzugriff (PDF)

IMPACT OF CARING FOR INDIVIDUALS WITH HEART FAILURE IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW

Journal of the American College of Cardiology, 2022-03, Vol.79 (9), p.439

2022

Volltextzugriff (PDF)

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker

Current medical research and opinion, 2007-06, Vol.23 (6), p.1239-1244

2007

Volltextzugriff (PDF)

Clinical and economic impact of intravenous to oral conversion therapy programs

Connecticut medicine, 2011-01, Vol.75 (1), p.25

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial

American journal of kidney diseases, 2022-06, Vol.79 (6), p.796-806

2022

Volltextzugriff (PDF)

Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis

Current medical research and opinion, 2017-10, Vol.33 (10), p.1795-1801

2017

Volltextzugriff (PDF)

Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both

Current medical research and opinion, 2020-12, Vol.36 (12), p.1927-1938

2020

Volltextzugriff (PDF)

103-LB: Impact of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in COVID-19 Patients with Preexisting Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD)

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease

Journal of managed care & specialty pharmacy, 2018-03, Vol.24 (3), p.280

2018

Volltextzugriff (PDF)

809-P: The Impact of High-Deductible Health Plans (HDHPS) and Out-of-Pocket (OOP) Costs on Access to Care in Diabetes

Diabetes (New York, N.Y.), 2021-06, Vol.70 (Supplement_1)

2021

Volltextzugriff (PDF)

Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID‐19

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2464-2472

2023

Volltextzugriff (PDF)

Abstract 275: Cost of Hospitalization for Heart Failure in the United States: A Systematic Literature Review

Circulation Cardiovascular quality and outcomes, 2020-05, Vol.13 (Suppl_1)

2020

Volltextzugriff (PDF)

163-LB: Impact of Preexisting Type 2 Diabetes (T2D) and Concurrent Cardiovascular Disease (CVD) on Patients with COVID-19 (C-19)

Diabetes (New York, N.Y.), 2022-06, Vol.71 (Supplement_1)

2022

Volltextzugriff (PDF)

Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes

Journal of comparative effectiveness research, 2022-12, Vol.11 (18), p.1349-1363

2022

Volltextzugriff (PDF)

Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19

Journal of health economics and outcomes research (Online), 2024-01, p.112-121

2024

Volltextzugriff (PDF)

Effect of a medication assistance program on clinical outcomes in patients with diabetes

Formulary (Cleveland, Ohio), 2006-10, Vol.41 (10), p.518

2006

Volltextzugriff (PDF)

Abstract 9668: Greater Than the Sum of Its Parts: The Risk of Future Cardiovascular Disease (CVD) in Patients With Type 2 Diabetes (T2D), Prior Cardiovascular Disease or Both

Circulation (New York, N.Y.), 2019-11, Vol.140 (Suppl_1 Suppl 1), p.A9668-A9668

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(17)
Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Aged
(6)
Pharmacology & Pharmacy
(6)
Cardiovascular Diseases
(5)
Diabetes
(5)
Diabetes Mellitus
(5)
General & Internal Medicine
(5)
Adult
(4)
Cardiovascular Diseases - Epidemiology
(4)
Covid-19
(4)
Female
(4)
Health Care Sciences & Services
(4)
Mortality
(4)
Retrospective Studies
(4)
United States
(4)
Anti-Bacterial Agents - Therapeutic Use
(3)
Antibiotics
(3)
Cardiovascular Disease
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Caring for Individuals With Heart Failure in the United States: A Systematic Literature Review

Burden of hospitalization for heart failure in the United States: a systematic literature review

Cost-Effectiveness Analysis of Empagliflozin for Treatment of Patients With Heart Failure With Reduced Ejection Fraction in the United States

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: A meta-analysis

Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19

Pharmacokinetics, antifungal activity and clinical efficacy of anidulafungin in the treatment of fungal infections

Length of Stay and Hospital Costs Associated with a Pharmacodynamic-Based Clinical Pathway for Empiric Antibiotic Choice for Ventilator-Associated Pneumonia

Response to “Duplicate patient data in a meta-analysis; A threat to validity”

Student Measurement of Blood Pressure Using a Simulator Arm Compared with a Live Subject's Arm

IMPACT OF CARING FOR INDIVIDUALS WITH HEART FAILURE IN THE UNITED STATES: A SYSTEMATIC LITERATURE REVIEW

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker

Clinical and economic impact of intravenous to oral conversion therapy programs

Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial

Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis

Assessing risk of future cardiovascular events, healthcare resource utilization and costs in patients with type 2 diabetes, prior cardiovascular disease and both

103-LB: Impact of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) and Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in COVID-19 Patients with Preexisting Type 2 Diabetes (T2D) and Cardiovascular Disease (CVD)

Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease

809-P: The Impact of High-Deductible Health Plans (HDHPS) and Out-of-Pocket (OOP) Costs on Access to Care in Diabetes

Impact of pre‐existing type 2 diabetes with and without cardiovascular disease on patients with COVID‐19

Abstract 275: Cost of Hospitalization for Heart Failure in the United States: A Systematic Literature Review

163-LB: Impact of Preexisting Type 2 Diabetes (T2D) and Concurrent Cardiovascular Disease (CVD) on Patients with COVID-19 (C-19)

Evaluation of emerging NASH therapies: the impact of treatment efficacy profiles on long-term health outcomes

Impact of Pre-existing Type 2 Diabetes Mellitus and Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With COVID-19

Effect of a medication assistance program on clinical outcomes in patients with diabetes

Abstract 9668: Greater Than the Sum of Its Parts: The Risk of Future Cardiovascular Disease (CVD) in Patients With Type 2 Diabetes (T2D), Prior Cardiovascular Disease or Both

Suchergebnisse filtern